Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benznidazole in Children With Chronic Indeterminate Chagas Disease
NCT04024163Phase 3Active, not recruiting
- Sponsor
- Insud Pharma
- Start
- Sep 2019
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of benznidazole in Chagas disease, sponsored by Insud Pharma. Started Sep 2019; status: active, not recruiting.
02
Drugs
benznidazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT04024163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04024163.